Aprameya Engineering Limited reported a decline in financial performance for the year ended 31st March, 2026, impacted by temporary working capital constraints and administrative transitions in government departments. The company's board approved the audited standalone and consolidated financial results on 28th May, 2026. Despite the revenue contraction, the company highlighted a significant normalisation in collections, a reduction in trade receivables, and a strategic pivot towards a product-led platform with new geographical diversification.

Financial Performance

For the full year ended 31st March, 2026, consolidated revenue from operations stood at ₹5,513.14 Lakhs compared to ₹13,570.71 Lakhs in the previous year. Profit after tax for the year was ₹512.81 Lakhs, a decrease from ₹1,611.61 Lakhs in the prior year. The second half of FY26 recorded a consolidated loss before tax of ₹184.75 Lakhs and a loss after tax of ₹163.27 Lakhs. On a standalone basis, revenue from operations was ₹5,474.75 Lakhs, with a profit after tax of ₹504.11 Lakhs.

The following table presents the key consolidated financial results for the year ended 31st March, 2026 (₹ In Lakhs):

Operational Highlights and Balance Sheet

The company attributed the decline in profitability to delays in approvals and receivable collections due to administrative reshuffling in certain government departments. However, it confirmed that a major portion of pending receivables was recovered by the end of March 2026, with the remaining balance received in the first week of April 2026. Consequently, trade receivables reduced significantly to ₹55.52 Crore in FY26 from ₹119.12 Crore in FY25. Net cash from operating activities improved to ₹31.23 Crore from a negative ₹10.64 Crore in the previous year, while cash and bank balances increased to ₹5.89 Crore.

Strategic Developments

Aprameya Engineering is transitioning from a project-led model to a diversified healthcare infrastructure and product-led platform. The company incorporated a subsidiary, Aprameya Medtech Private Limited, on 4th October, 2025, holding a 70% stake. It is in an advanced stage of discussion for an exclusive channel distribution partnership for MIS (Endo Vision) robotic healthcare products. Additionally, the company is pursuing geographical de-risking by expanding its presence across multiple states and healthcare institutions to reduce dependence on a single geography. Management stated that the company has recovered total outstanding receivables of approximately ₹100 Crores and has submitted bids on tenders amounting to approximately ₹190 Crores to date.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE0LQG01010/cb6f747b81a84a3f.pdf

Aprameya Engineering has reported a remarkable financial turnaround in the first half of the current fiscal year, showcasing significant improvements in both profitability and revenue.

Financial Highlights

Turnaround in Profitability

Aprameya Engineering has demonstrated a substantial improvement in its financial performance, reporting a net profit of ₹68.00 crore for the first half of the current fiscal year. This marks a significant turnaround from the ₹18.00 crore loss recorded in the corresponding period of the previous year.

Revenue Surge

The company's top-line growth has been equally impressive. Aprameya Engineering's revenue surged to ₹421.00 crore in H1, compared to ₹93.00 crore in the same period last year. This represents a remarkable year-over-year increase of approximately 352.69%.

Analysis

The dramatic improvement in both profitability and revenue suggests that Aprameya Engineering may have implemented effective strategies to enhance its operational efficiency and expand its market presence. The transition from a loss-making position to a profitable one, coupled with the substantial revenue growth, indicates a potentially positive shift in the company's business dynamics.

However, it's important to note that these figures represent half-yearly results, and sustained performance over a longer period would provide a more comprehensive picture of the company's financial health and growth trajectory.

Investors and market observers may want to keep an eye on Aprameya Engineering's future quarterly results to assess whether this strong performance is part of a consistent trend or a one-time occurrence. Additionally, understanding the factors behind this turnaround, such as potential new contracts, improved market conditions, or internal restructuring, could offer valuable insights into the company's future prospects.